CAS: 35303-76-5; 4-(2-Aminoethyl)Benzenesulfonamide

该化合物是在药用化学领域,因为磺酰胺已被用作抗菌剂;氨基基乙酸副链可参与氢的结合,加强其与生物目标的相互作用;此外,全氟辛烷磺酸组的存在有助于其酸性,使其在溶液中能够作为微弱的酸.总体而言,4-(2-氨乙基)苯基二硝胺是一种多种化合物,在制药和生物化学领域应用,特别是在研制针对细菌感染的药物方面.

结构式图片

欧盟法规

REACH注册ECHA物质C&L通报REACH预注册

上下游产品

CAS号3665-08-5 Benzenesulfonam... | CAS号41472-49-5 N-[2-[4-(氨基磺酰基)... | CAS号877-95-2 N-(2-苯乙基)乙酰胺 | CAS号35450-53-4 p-(2-acetamidoe... | CAS号41472-49-5 N-[2-[4-(氨基磺酰基)... | CAS号10079-93-3 1-phenyl-3-[2-(... | CAS号345970-48-1 4-[2-[(4-aminop... | CAS号16673-34-0 4-[2-(5-氯-2-甲氧基... | CAS号59477-42-8 4-chloro-N-[2-(... | CAS号54160-75-7 1-methyl-1-phen...

合成工艺路线路线简述

  • 合成目标产物 4-(2-Aminoethyl)Benzenesulfonamide 主要起始原料 N-Acetyl-2-Phenylethylamine
  • (文献来源)合成步骤主要原料 N-Acetyl-2-Phenylethylamine
4-(氰基甲基)苯磺酰胺置于镍 Sodium Methylate体系中,用 甲醇 作为反应溶剂,以86%的收率获得产物4-(2-氨乙基)苯磺酰胺
参考文献:氰基磺酰胺的电化学还原新合成马芬尼德和其他氨基磺酰胺
标题:氰基磺酰胺的电化学还原新合成马芬尼德和其他氨基磺酰胺
摘要:脂肪族和芳香族氨基磺酰胺类化合物(如马芬尼(1A))是通过在含ni阴极,Pt阳极和阮内ni作为催化剂的未分隔电池中将相应的腈直接电化学加氢而以高收率(80-86%)合成的(表1).该反应可以在不通过原位产生h 2的外部供应加压气体的情况下进行.略微升高温度(45°)和低电流密度(10 Ma / Cm 2)是这种类型的电化学腈加氢的有利条件.我们的合成规程不需要高压设备或化学危害,在环境方面非常友好,比传统方法更经济.吸附的h的浓度.通过调节电势可以轻松控制催化剂表面的自由基,这可以提高产品的选择性,同时降低爆炸和着火的风险.
DOI:10.1002/hlca.200690123

海关参考信息

专利信息


专利号:US-5877278-A
优先权日:1992-09-24
标题:Synthesis of N-substituted oligomers
发明人:ZUCKERMANN RONALD N; GOFF DANE A; NG SIMON; SPEAR KERRY; SCOTT BARBARA O; SIGMUND AARON C; GOLDSMITH RICHARD A; MARLOWE CHARLES K; PEI YAZHONG; RICHTER LUTZ; SIMON REYNA
权利人:CHIRON CORP
摘要:A solid-phase method for the synthesis of N-substituted oligomers, such as poly (N-substituted glycines) (referred to herein as poly NSGs) is used to obtain oligomers, such as poly NSGs of potential therapeutic interest which poly NSGs can have a wide variety of side-chain substituents. Each N-substituted glycine monomer is assembled from two 'sub-monomers' directly on the solid support. Each cycle of monomer addition consists of two steps: (1) acylation of a secondary amine bound to the support with an acylating agent comprising a leaving group capable of nucleophilic displacement by -NH2, such as a haloacetic acid, and (2) introduction of the side-chain by nucleophilic displacement of the leaving group, such as halogen (as a solid support-bound alpha -haloacetamide) with a sufficient amount of a second sub-monomer comprising an -NH2 group, such as a primary amine, alkoxyamine, semicarbazide, acyl hydrazide, carbazate or the like. Repetition of the two step cycle of acylation and displacement gives the desired oligomers. The efficient synthesis of a wide variety of oligomeric NSGs using automated synthesis technology of the present method makes these oligomers attractive candidates for the generation and rapid screening of diverse peptidomimetic libraries. The oligomers of the invention, such as N-substituted glycines (i.e. poly NSGs) disclosed here provide a new class of peptide-like compounds not found in nature, but which are synthetically accessible and have been shown to possess significant biological activity and proteolytic stability. Combinatorial libraries of cyclic compounds are disclosed wherein the cyclic compounds are comprised of at least one ring structure derived from cyclization of a peptoid backbone. The diversity of product compounds is generated by the sequential addition of substituted submonomers. The combinatorial library includes 10 or more, preferably 100 or more, and more preferably 1,000 or more distinct and different compounds. The library includes each of the product compounds in retrievable and analyzable amounts and preferably includes at least one biologically active compound. Methods of synthesizing the combinatorial libraries and assay devices produced using the libraries are disclosed as is methodology for screening for and obtaining biologically active cyclic organic compounds.

专利号:WO-0140193-A1
优先权日:1999-12-03
标题:Method for the synthesis of pyrazolines
发明人:BOLDI ARMEN M
权利人:CHEMRX ADVANCED TECHNOLOGIES I; BOLDI ARMEN M
摘要:The present invention provides a method for the synthesis of compounds of Formula (I). Also claimed are novel intermediates and their methods of synthesis.

专利号:US-2002103381-A1
优先权日:2000-11-30
标 题 :Method for the synthesis of pyrazolines
发明人:BOLDI ARMEN M
摘要:The present invention provides a method for the synthesis of compounds of Formula I: n n n Also claimed are novel intermediates and their methods of synthesis.

专利号:US-7138526-B1
优先权日:1999-06-15
标 题 :Solid phase synthesis of n,n-disubstituted diazacycloalkylcarboxy derivatives
发明人:HERPIN TIMOTHY F; MORTON GEORGE C; SALVINO JOSEPH M
权利人:AVENTIS PHARMA INC
摘要:A method for the solid phase synthesis of N,N-disubstituted diazacycloalkylcarboxy derivatives of general formula (I) and (II) is claimed. Examples include piperazine-2-carboxamide. The method is applicable to the synthesis or large combinatorial libraries

专利号:US-7109377-B2
优先权日:1996-10-16
标 题:Synthesis of combinatorial libraries of compounds reminiscent of natural products
发明人:SCHREIBER STUART L; SHAIR MATTHEW D; TAN DEREK S; FOLEY MICHAEL A; STOCKWELL BRENT R
权利人:HARVARD COLLEGE
摘要:The present invention provides complex compounds reminiscent of natural products and libraries thereof, as well as methods for their production. The inventive compounds and libraries of compounds are reminiscent of natural products in that they contain one or more stereocenters, and a high density and diversity of functionality. In general, the inventive libraries are synthesized from diversifiable scaffold structures, which are synthesized from readily available or easily synthesizable template structures. In certain embodiments, the inventive compounds and libraries are generated from diversifiable scaffolds synthesized from a shikimic acid based epoxyol template. In other embodiments, the inventive compounds and libraries are generated from diversifiable scaffolds synthesized from the pyridine-based template isonicotinamide. The present invention also provides a novel ortho-nitrobenzyl photolinker and a method for its synthesis. Furthermore, the present invention provides methods and kits for determining one or more biological activities of members of the inventive libraries. Additionally, the present invention provides pharmaceutical compositions containing one or more library members.

专利号:US-2007082943-A1
优先权日:2005-04-01
标 题:Process for preparation of substantially pure glimepiride
发明人:KADAM SURESH M; TARUR VENKATASUBRAMANIAN R; NAIK SANJAY J; GAVHANE SACHIN B
权利人:KADAM SURESH M; TARUR VENKATASUBRAMANIAN R; NAIK SANJAY J; GAVHANE SACHIN B
摘要:The present invention discloses a novel process for purification of trans-4-methyl cyclohexylamine HCl and 4[-2-(3-Ethyl-4-methyl-2-carbonyl pyrrolidine amido) ethyl] benzene sulfonamide used in the synthesis of 3-Ethyl-2,5-dihydro-4-methyl-N-[2-[4-[[[[(trans-4-methyl cyclohexyl)amino]carbonyl]amino]sulfonyl]phenyl]ethyl]-2-oxo-1H-pyrrole-1-carboxamide (I), popularly known as Glimepiride. The present invention also discloses a novel purification of Glimepiride usingS methanolic ammonia and glacial acetic acid to obtain highly pure Glimepiride Form I (I) having the undesired cis isomer below 0.15%. Glimepiride (I) is useful in the treatment of diabetes mellitus.
江苏省金坛市兢业医化技术研究所
⚠️ 未注册 · 未认证企业
⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
数据来源于公开网络搜索,平台未作核实,请自行辨别。
🏢敬请 企业认领
🏬开设公司展台
📢获取免费会员权益
🎖️点亮专属注册企业标签
📇展现公司完整信息 样本查看立即注册认领 →
网址: http://www.jy-chem.com
电话: 0519-82765788 82765761👤
📞江苏省金坛市兢业医化技术研究所 ⚠️参考联系方式

销售电话:0519-82765788 82765761
邮箱:yeyin@depeichem.com
🆔 联系时候可告知是从"百琢研"平台获取的信息.
⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

⚠️ 未注册 · 未认证企业
注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别 ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
上海磐沃精细化工有限公司
⚠️ 未注册 · 未认证企业
⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
数据来源于公开网络搜索,平台未作核实,请自行辨别。
🏢敬请 企业认领
🏬开设公司展台
📢获取免费会员权益
🎖️点亮专属注册企业标签
📇展现公司完整信息 样本查看立即注册认领 →
网址: http://www.pinewoodchem.com
企业联系电话:021-62417129/62414096👤
📞上海磐沃精细化工有限公司 ⚠️参考联系方式
联系人:张超,仇正
电话:021-62417129/62414096

传真:021-62410511
邮箱:timzhang@pinewood-sales.com,irene.wei@pinewood-sales.com,june@huapaigroup.com
通信地址: 上海市天山路600弄2号捷运大厦27楼B座
邮编: 200461
🆔 联系时候可告知是从"百琢研"平台获取的信息.
⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

地址:上海市天山路600弄2号捷运大厦27楼B座
⚠️ 未注册 · 未认证企业
注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
天津药物研究院药业有限责任公司
⚠️ 未注册 · 未认证企业
⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
数据来源于公开网络搜索,平台未作核实,请自行辨别。
🏢敬请 企业认领
🏬开设公司展台
📢获取免费会员权益
🎖️点亮专属注册企业标签
📇展现公司完整信息 样本查看立即注册认领 →
网址: http://www.cnpha.com
电话: 022-23009155 23006946👤
📞天津药物研究院药业有限责任公司 ⚠️参考联系方式

销售电话:022-23009155 23006946
邮箱:api@cnpha.com
🆔 联系时候可告知是从"百琢研"平台获取的信息.
⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

⚠️ 未注册 · 未认证企业
注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别 ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
济南德瑞丰环保化工有限公司
⚠️ 未注册 · 未认证企业
⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
数据来源于公开网络搜索,平台未作核实,请自行辨别。
🏢敬请 企业认领
🏬开设公司展台
📢获取免费会员权益
🎖️点亮专属注册企业标签
📇展现公司完整信息 样本查看立即注册认领 →
网址: http://www.jndrfhg.com
电话: 13854196079👤
📞济南德瑞丰环保化工有限公司 ⚠️参考联系方式

销售电话:13854196079
邮箱:sales@deruifengchem.com
🆔 联系时候可告知是从"百琢研"平台获取的信息.
⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

⚠️ 未注册 · 未认证企业
注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别 ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
湖北中隆康盛精细化工有限公司
⚠️ 未注册 · 未认证企业
⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
数据来源于公开网络搜索,平台未作核实,请自行辨别。
🏢敬请 企业认领
🏬开设公司展台
📢获取免费会员权益
🎖️点亮专属注册企业标签
📇展现公司完整信息 样本查看立即注册认领 →
网址: http://www.hbzlkschem.com
企业联系电话:027-83855385👤
📞湖北中隆康盛精细化工有限公司 ⚠️参考联系方式
联系人:丁女士
电话:027-83855385
手机:13407122916
传真:027-82752821
邮箱:hbzlkschem@163.com
通信地址: 江汉区常青路163号
邮编: 430000
🆔 联系时候可告知是从"百琢研"平台获取的信息.
⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

地址:江汉区常青路163号
⚠️ 未注册 · 未认证企业
注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
济南德诚和牧医药科技有限公司
⚠️ 未注册 · 未认证企业
⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
数据来源于公开网络搜索,平台未作核实,请自行辨别。
🏢敬请 企业认领
🏬开设公司展台
📢获取免费会员权益
🎖️点亮专属注册企业标签
📇展现公司完整信息 样本查看立即注册认领 →
网址: http://www.jndecheng.com
企业联系电话:0531-62325949 18615171096👤
📞济南德诚和牧医药科技有限公司 ⚠️参考联系方式
联系人:肖经理
电话:0531-62325949 18615171096
手机:18615171096
传真:0531-68658860
邮箱:dcyy@vip.sina.com
通信地址: 山东省济南市高新区留学人员创业园2号楼
邮编: 250100
🆔 联系时候可告知是从"百琢研"平台获取的信息.
⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

地址:山东省济南市高新区留学人员创业园2号楼
⚠️ 未注册 · 未认证企业
注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
第 1 / 1 页
现货

供应商参考报价(招募中)

品牌试剂参考报价(招募中)

📌 第三方产品分析报告

✅ COA系统入驻 | 共享模式

主要参考文献

[参考文献]: C H Mastrangelo, Et Al. Probing Protein Binding Spectra With Fourier Microfluidics. Annu Int Conf Ieee Eng Med Biol Soc. 2010:2010:5318-21.
[参考文献]: Layne D Williams, Et Al. Low Noise Detection Of Biomolecular Interactions With Signal-Locking Surface Plasmon Resonance. Anal Chem. 2010 Jul 15;82(14):6025-31.
[参考文献]: Shanshan Qin, Et Al. Multiple Ligand Detection And Affinity Measurement By Ultrafiltration And Mass Spectrometry Analysis Applied To Fragment Mixture Screening. Anal Chim Acta. 2015 Jul 30:886:98-106.
[参考文献]: Su-Jong Yu, Et Al. Inhibition Of Hypoxia-Inducible Carbonic Anhydrase-Ix Enhances Hexokinase Ii Inhibitor-Induced Hepatocellular Carcinoma Cell Apoptosis. Acta Pharmacol Sin. 2011 Jul;32(7):912-20.

合成参考文献


参考文献:10.1021/jm901855h
摘要:Joseph P, Turtaut F, Ouahrani-Bettache S, Montero JL, Nishimori I, Minakuchi T, Vullo D, Scozzafava A, Köhler S, Winum JY, Supuran CT. Cloning, characterization, and inhibition studies of a beta-carbonic anhydrase from Brucella suis. J Med Chem. 2010 Mar 11;53(5):2277–85. doi: 10.1021/jm901855h.
参考文献:10.1016/j.bmc.2011.06.038
摘要:Nishimori I, Minakuchi T, Vullo D, Scozzafava A, Supuran CT. Inhibition studies of the β-carbonic anhydrases from the bacterial pathogen Salmonella enterica serovar Typhimurium with sulfonamides and sulfamates. Bioorg Med Chem. 2011 Aug 15;19(16):5023–30. doi: 10.1016/j.bmc.2011.06.038.
📝 需求与反馈
尽可能描述清楚需求与问题信息
×

通知